References
- Clarke M , CollinsR, DarbySet al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet366(9503), 2087–2106 (2005).
- Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) . Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet378(9804), 771–784 (2011).
- Anderson SJ , WapnirI, DignamJJet al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer. J. Clin. Oncol.27(15), 2466–2473 (2009).
- Hughes KS , SchnaperLA, BellonJRet al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. J. Clin. Oncol.31(19), 2377–2381 (2013).
- Nguyen PL , TaghianAG, KatzMSet al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J. Clin. Oncol.26(14), 2373–2378 (2008).
- Arvold ND , TaghianAG, NiemierkoAet al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J. Clin. Oncol.29(29), 3885–3891 (2011).
- Haviland JS , OwenJR, DewarJAet al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomized controlled trials. Lancet Oncol.14(11), 1086–1094 (2013).
- Whelan TJ , PignolJP, LevineMNet al. Long-term results of hypofractionated radiation therapy for breast cancer. N. Engl. J. Med.362(6), 513–520 (2010).
- Guiliano AE , HuntKV, BallmanKKet al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastases: a randomized clinical trial. JAMA305(6), 569–575 (2011).
- Whelan TJ , OlivottoIA, ParulekarWRet al. Regional nodal irradiation in early-stage breast cancer. N. Engl. J. Med.373(19), 307–316 (2015).
- Poortmans PM , ColletteS, KirkoveCet al. Internal mammary and medial supraclavicular irradiation in breast cancer. N. Engl. J. Med.373(4), 317–327 (2015).
- Loi S , SirtaineN, PietteFet al. Prognostic and predictive value of tumor-infiltrating lymphocytes in a Phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98. J. Clin. Oncol.31(7), 860–867 (2013).
- Disis ML , PatelMR, PantSet al. Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with previously treated, recurrent or refractory ovarian cancer: a Phase Ib, open-label expansion trial. J. Clin. Oncol.33(Suppl.), Abstract5509 (2015).